Early Cost-Effectiveness Modeling for Tumor Infiltrating Lymphocytes (TIL) -Treatment Versus Ipilimumab in Metastatic Melanoma Patients

Saved in:
Bibliographic Details
Published in:Value in health 2014-11, Vol.17 (7), p.A640-A640
Main Authors: Retèl, V.P, Steuten, L.M.G, Mewes, J.C, van Harten, W.H
Format: Article
Language:English
Subjects:
Internal Medicine
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:1098-3015
1524-4733
DOI:10.1016/j.jval.2014.08.2307